Skip to Main Content

Paper Details

Newer and Emerging LDL-C Lowering Agents and Implications for ASCVD Residual Risk.
J Clin Med
5
2022
Author NameAffiliation
Michael D ShapiroCenter for Prevention of Cardiovascular Disease, Wake Forest School of Medicine
  • 1 - 1

Datasets

Release 1.2